Alan D. Watson

Corporate Officer/Principal at

Targeted Diagnostics & Therapeutics, Inc.

73 year

3 connections

Health Technology

Consumer Services

Finance

Profile

Dr. Alan D.
Watson is a Director at IMCOR Pharmaceutical Co., Vice President-Business Development at SmartCells, Inc., and Entrepreneur-in-Residence at Oxford Bioscience Partners.
He is on the Board of Directors at IMCOR Pharmaceutical Co. and Targeted Diagnostics & Therapeutics, Inc. Dr. Watson was previously employed as Senior Vice President-Corporate Development by Cubist Pharmaceuticals, Inc. He received his undergraduate degree from The University of New South Wales, an MBA from Northeastern University, and a doctorate degree from Australian National University.

Alan D. Watson active positions

Companies	Position	Start
Targeted Diagnostics & Therapeutics, Inc. Targeted Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostics and therapeutics	Corporate Officer/Principal	-

All active positions of Alan D. Watson

Former positions of Alan D. Watson

Companies	Position	End
Oxford Bioscience Partners Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations.	Corporate Officer/Principal	-
CUBIST PHARMACEUTICALS INC	Corporate Officer/Principal	-
SmartCells, Inc. SmartCells, Inc. Medical SpecialtiesHealth Technology Develops breakthrough treatment for diabetes called SmartInsulin	Corporate Officer/Principal	-
IMCOR Pharmaceutical Co. IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology Develops medical imaging pharmaceutical products	Director/Board Member	-

See the detail of Alan D. Watson's experience

Training of Alan D. Watson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alan D. Watson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Cubist Pharmaceuticals LLC Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products	Health Technology
Oxford Bioscience Partners Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations.	Finance
IMCOR Pharmaceutical Co. IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology Develops medical imaging pharmaceutical products	Health Technology
Targeted Diagnostics & Therapeutics, Inc. Targeted Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostics and therapeutics	Health Technology
SmartCells, Inc. SmartCells, Inc. Medical SpecialtiesHealth Technology Develops breakthrough treatment for diabetes called SmartInsulin	Health Technology
Australian National University Australian National University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Northeastern University Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of New South Wales The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services